Algo version: 0.98b
Integrated Diagnostics is listed at the LSE Exchange
Integrated Diagnostics [IDHC.L]
LSE Sector: Industry:Health Care Equipment & Services

Is Integrated Diagnostics stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Integrated Diagnostics pays dividends. Last time was Wednesday 27th of July 2022 where the investors holding the stock on Thursday 16th of June 2022 were paid $0.116 per share. Over the last 7 times between 2016 and 2022, Integrated Diagnostics has paid $0.888 with an average of $0.13 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Integrated Diagnostics 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was $1.158, you would have made a loss of $-0.738 per share or -63.71%

No, the average daily trading liquidity for Integrated Diagnostics is $63 612 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Integrated Diagnostics has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.66, the company's ability to pay off the debt is good. Integrated Diagnostics has a good net profit margin of 17.21% and should have high tolerances against inflation.

We have calculated the inflation risk for Integrated Diagnostics to be low [0.25 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.